Amyloid-β peptide binds to microtubule-associated protein 1B (MAP1B)

Neurochemistry International

Volumn 52, Issue 6, 2008, Pages 1030-1036

  Gevorkian, Goar ^a   Gonzalez Noriega, Alfonso ^a   Acero, Gonzalo ^a   Ordoñez, Jorge ^a   Michalak, Colette ^a   Munguia, Maria Elena ^a   Govezensky, Tzipe ^a   Cribbs, David H ^b,c   Manoutcharian, Karen ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid beta peptide; Microtubule associated protein 1B (MAP1B); Phage displayed cDNA library

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; MICROTUBULE ASSOCIATED PROTEIN 5;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; HEAVY CHAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SCREENING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; CELL LINE, TUMOR; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; NEURONS; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; SYNAPTIC TRANSMISSION;

EID: 40949096957     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.10.020     Document Type: Article

References (60)

1. Aleardi A.M., Benard G., Augereau O., Malgat M., Talbot J.C., Mazat J.P., Letellier T., Dachary-Prigent J., Solaini G.C., and Rossignol R. Gradual alteration of mitochondrial structure and function by β-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release. J. Bioenerg. Biomembr. 37 (2005) 207-225
2. Avila J., Lim F., Moreno F., Belmonte C., and Cuello A.C. Tau function and dysfunction in neurons. Its role in neurodegenerative disorders. Mol. Neurobiol. 25 (2002) 213-231
3. Bales K.R., Tzavara E.T., Wu S., Wade M.R., Bymaster F.P., Paul S.M., and Nomktos G.G. Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody. J. Clin. Invest. 116 (2006) 825-832
4. Behl C., Davis J.B., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77 (1994) 817-827
5. Billings L.M., Oddo S., Green K.N., McGaugh J.L., and LaFerla F.M. Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45 (2005) 675-688
6. Billups D., Hanley J.G., Orme M., Attwell D., and Moss S.J. GABAc receptor sensitivity is modulated by interaction with MAP1B. J. Neurosci. 20 (2000) 8643-8650
7. Buckig A., Tikkanen R., Herzog V., and Schmitz A. Cytosolic and nuclear aggregation of the amyloid β-peptide following its expression in the endoplasmic reticulum. Histochem. Cell Biol. 118 (2002) 353-360
8. Busciglio J., Lorenzo A., Yeh J., and Yankner B.A. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14 (1995) 879-888
9. Butler D., Bendiske J., Michaelis M.L., Karanian D.A., and Bahr B.A. Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers. Eur. J. Pharmacol. 562 (2007) 20-27
10. Butterfield D.A., and Boyd-Kimball D. Amyloid beta-peptide (1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol. 14 (2004) 426-432
11. Canevari L., Abramov A.Y., and Duchen M.R. Toxicity of amyloid β peptide: tales of calcium, mitochondria, and oxidative stress. Neurochem. Res. 29 (2004) 637-650
12. Casley C.S., Canevari L., Land J.M., Clark J.B., and Sharpe M.A. β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80 (2002) 91-100
13. Chromy B.A., Nowak R.J., Lambert M.P., Viola K.L., Chang L., Velasko P.T., Jones B.W., Fernandez S.J., Lacor P.N., Horowitz P., Finch C.E., Krafft G.A., and Klein W.L. Self-assemlbly of Abeta(1-42) into globular neurotoxins. Biochemistry 42 (2003) 12749-12760
14. Cueille N., Tallichet Blanc C., Popa-Nita S., Kasas S., Catsicas S., Dietler G., and Riederer B.M. Characterization of MAP1B heavy chain interaction with actin. Brain Res. Bull. 71 (2007) 610-618
15. Edelmann W., Zervas M., Costello P., Roback L., Fischer I., Hammarback J.A., Cowan N., Davies P., Wainer B., and Kucherlapati R. Neuronal abnormalities in microtubule-associated protein 1B mutant mice. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 1270-1275
16. Fernandez-Vizarra P., Fernandez A.P., Castro-Blanco S., Serrano J., Bentura M.L., Martinez-Murillo R., Martinez A., and Rodrigo J. Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. Histol. Histopathol. 19 (2004) 823-844
17. Franzen R., Tanner S.L., Dashiell S.M., Rottkamp C.A., Hammer J.A., and Quarles R.H. Microtubule-associated protein 1B: a neuronal binding partner for myelin-associated glycoprotein. J. Cell Biol. 155 (2001) 893-898
18. Gonzalez-Billault C., Jimenez-Mateos E.M., Caceres A., Diaz-Nido J., Wandosell F., and Avila J. Microtubule-associated protein 1B function during normal development, regeneration, and pathological conditions in the nervous system. J. Neurobiol. 58 (2004) 48-59
19. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., and Relkin N.R. Intraneuronal Aβ42 accumulation in human brain. Am. J. Pathol. 156 (2000) 15-20
20. Gregori L., Hainfeld J.F., Simon M.N., and Goldgaber D. Binding of amyloid beta protein to the 20 S proteasome. J. Biol. Chem. 272 (1997) 58-62
21. Hamos J.E., DeGennaro L.J., and Drachman D.A. Synaptic loss in Alzheimer's disease and other dementias. Neurology 39 (1989) 355-361
22. He X.Y., Schulz H., and Yang S.Y. A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an amyloid β-peptide-binding protein involved in Alzheimer's disease. J. Biol. Chem. 273 (1998) 10741-10746
23. Huang X., Moir R.D., Tanzi R.E., Bush A.I., and Rogers J.T. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann. NY Acad. Sci. 1012 (2004) 153-163
24. Iversen L.L., Mortishire-Smith R.J., Pollack S.J., and Shearman M.S. The toxicity in vitro of beta-amyloid protein. Biochem. J. 311 (1995) 1-16
25. Kar S., Slowikowski S.P., Westaway D., and Mount H.T. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J. Psychiatry Neurosci. 29 (2004) 427-441
26. Kins S., and Beyreuther K. Teasing out the tangles. Nat. Med. 12 (2006) 764-765
27. Kokubo H., Kayed R., Glabe C.G., and Yamaguchi H. Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Brain Res. 1031 (2005) 222-228
28. LaFerla F., Green K.N., and Oddo S. Intracellular amyloid-β in Alzheimer's disease. Nat. Rev. Neurosci. 8 (2007) 499-509
29. Lakshmana M.K., Araki W., and Tabira T. Amyloid beta peptide binds a novel death-inducing protein. AB-DIP FASEB J. 19 (2005) 1362-1364
30. Lustbader J.W., Cirilli M., Lin C., Xu H.W., Takuma K., Wang N., Caspersen C., Chen X., Pollak S., Chaney M., Trinchese F., Liu S., Gunn-Moore F., Lue L.F., Walker D.G., Kuppusamy P., Zewier Z.L., Arancio O., Stern D., Yan S.S., and Wu H. ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease. Science 304 (2004) 448-452
31. Manoutcharian K., Acero G., Munguia M.E., Montero J.A., Govezensky T., Cao C., Ugen K., and Gevorkian G. Amyloid-beta peptide specific single chain Fv antibodies isolated from an immune phage display library. J. Neuroimmunol. 145 (2003) 12-17
32. Michaelis M.L., Seyb K.I., and Ansar S. Cytoskeletal integrity as a drug target. Curr. Alzheimer Res. 2 (2005) 227-229
33. Mizuno T., Nakata M., Haiki H., Michikawa M., Wang R., Haass C., and Yanagisawa K. Cholesterol-dependent generation of a seeding amyloid β protein in cell culture. J. Biol. Chem. 274 (1999) 15110-15114
34. Morishima-Kawashima M., and Ihara Y. The presence of amyloid β-protein in the detergent insoluble membrane compartment of human neuroblastoma cells. Biochemistry 37 (1998) 15247-15253
35. Mudher A., and Lovestone S. Alzheimer's disease-do tauists and Baptists finally shake hands?. Trends Neurosci. 25 (2002) 22-26
36. Munguia M.E., Govezensky T., Martinez R., Manoutcharian K., and Gevorkian G. Identification of amyloid-beta 1-42 binding protein fragments by screening of a human brain cDNA library. Neurosci. Lett. 397 (2006) 79-82
37. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., and LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39 (2003) 409-421
38. Pereira C., Ferreiro E., Cardoso S.M., and de Oliveira C.R. Cell degeneration induced by amyloid-beta peptides: implications for Alzheimer's disease. J. Mol. Neurosci. 23 (2004) 97-104
39. Perez M., Cuadros R., Benitez M.J., and Jiménez J.S. Interaction of Alzheimer's disease amyloid beta peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain. J. Alzheimer Dis. 6 (2004) 461-467
40. Pike C.J., Cummings B.J., and Cotman C.W. β-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. Neuroreport 3 (1992) 769-772
41. Praprotnik D., Smith M.A., Richey P.L., Vinters H.V., and Perry G. Filament heterogeneity within the dystrophic neuritis of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease. Acta Neuropathol. 91 (1996) 226-235
42. Riederer B.M. Microtubule-associated protein 1B, a growth-associated and phosphorylated scaffold protein. Brain Res. Bull. 71 (2007) 541-558
43. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
44. Seog D.H. Glutamate receptor-interacting protein 1 protein binds to the microtubule associated protein. Biosci. Biotechnol. Biochem. 68 (2004) 1808-1810
45. Sponne I., Fifre A., Drouet B., Klein C., Koziel V., Pincon-Raymond M., Olivier J.L., Chambaz J., and Pillot T. Apoptotic neuronal cell death induced by the non-fibrillar amyloid-β peptide proceeds through an early reactive oxygen species-dependent cytoskeleton perturbation. J. Biol. Chem. 278 (2003) 3437-3445
46. Takahashi R.H., Milner T.A., Li F., Nam E.E., Edgar M.A., Yamaguchi H., Beal M.F., Xu H., Greengard P., and Gouras G.K. Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161 (2002) 1869-1879
47. Takemura R., Okabe S., Umeyama T., Kanai Y., Cowan N.J., and Hirokawa N. Increased microtubule stability and alpha tubulin acetylation in cells transfected with microtubule-associated proteins MAP1B, MAP2 or tau. J. Cell Sci. 103 (1992) 953-964
48. Takuma K., Yao J., Huang J., Xu H., Chen X., Luddy J., Trillat A.C., Stern D.M., Arancio O., and Yan S.S. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J. 19 (2005) 597-598
49. Tanner S., Franzen R., Jaffe H., and Quarles R.H. Evidence for expression of some microtubule-associated protein 1B in neurons as a plasma membrane glycoprotein. J. Neurochem. 75 (2000) 553-562
50. Tucker R.P., Garner C.C., and Matus A. In situ localization of microtubule-associated protein mRNA in the developing and adult rat brain. Neuron 2 (1989) 1245-1256
51. Uchida Y. Overexpression of full-length but not N-terminal truncated isoform of microtubule-associated protein (MAP) 1B accelerates apoptosis of cultured cortical neurons. J. Biol. Chem. 278 (2003) 366-371
52. Vasilevko V., and Cribbs D.H. Novel approaches for immunotherapeutic intervention in Alzheimer's disease. Neurochem. Int. 49 (2006) 113-126
53. Walsh D.M., and Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 (2004) 181-193
54. Walsh D.M., Tseng B.P., Rydel R.E., Podlisny M.B., and Selkoe D.J. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry 39 (2000) 10831-10839
55. Wirths O., Multhaup G., and Bayer T.A. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide-the first step of a fatal cascade. J. Neurochem. 91 (2004) 513-520
56. Yan S.D., and Stern D.M. Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD). Int. J. Exp. Pathol. 86 (2005) 161-171
57. Yan S.D., Fu J., Soto C., Chen X., Zhu H., Al-Mohanna F., Collison K., Zhu A., Stern E., Saido T., Tohyama M., Ogawa S., Roher A., and Stern D. An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389 (1997) 689-695
58. Yang H.Q., Ba M.W., Ren R.J., Zhang Y.H., Ma J.F., Pan J., Lu G.Q., and Chen S.D. Mitogen activated protein kinase and protein kinase c activation mediate promotion of sAPPa secretion by deprenyl. Neurochem. Int. 50 (2007) 74-82
59. Zervas M., Opitz T., Edelmann W., Wainer B., Kucherlapati R., and Stanton P.K. Impaired hippocampal long-term potentiation in microtubule-associated protein 1B-deficient mice. J. Neurosci. Res. 82 (2005) 83-92
60. Zhang C., Lambert M.P., Bunch C., Barber K., Wade W.S., Krafft G.A., and Klein W.L. Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosporylation in response to Alzheimer's A beta peptide. J. Biol. Chem. 269 (1994) 25247-25250